% | $
Quotes you view appear here for quick access.

Metabolix, Inc. Message Board

  • jos847 jos847 Apr 10, 2013 1:40 PM Flag


    What is relationship between Wacker Chemie, the new MBLX offices in Germany, Pharmafilter, and Metabolix?
    Certainly, management would not be making a technology transfer / up fitting ($2 million +) with a semi-socialist country / environment without knowing something the rest of us do not know!!!!! Less

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Antibiotics negotiates to sell 50% of the biotechnology business to German company Wacker Chemie
      The Board already know the deal, which is being delayed to fit legally participation
      28.02.13 - 12:49 -
      The German company Wacker Chemie in talks with the current owners of Antibiotics, Enerthi group to gain 50% of the business of biotechnology, but the operation was delayed to lock legally, as the company does not want to enter German division penicillin, the traditional business of the factory Leon, as reported in yesterday's edition 'Diario de León' and Ical agency collects.
      The interest of the German group, with more than 25 chemical plants in Europe, Asia and America, and is known by the Junta de Castilla y León. Apparently, the last 14, the plant management Leon led by President of Antibiotics, Danielle Pucci, his daughter, and the directors Pedro Ruiz, Director of Corporate Development, Jorge Guervós, 'controller' factory, and Stefano Celletti , assistant general manager to president, held a meeting in Valladolid with the Minister of Economy, Tomás Villanueva, who was accompanied by the CEOs of Labor and Industry.
      At that meeting, the direction of Antibiotics explained the current situation of the company and future plans, as well as the interest of the German group to enter the shareholder.
      Founded 1914, the German company sells more than 100 countries as silicone rubber products, polymer products and chemical materials of polysilicon and wafers for the semiconductor industry. Antibiotics would be interesting in future plans taking into account their experience, their technical level and the potential for new lines of work.
      Enerthi who took antibiotics in 2009, has chosen from the beginning to diversify, but without much success so far. Precisely the delay in plans with the American multinational Amirys farnesene for manufacturing a product from sugarcane with multiple possibilities, was one of the reasons alleged by the factory to present the ERE Leon las

0.40+0.03(+6.67%)Sep 23 4:00 PMEDT